Edgewise Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Edgewise Therapeutics (EWTX)
Edgewise Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Healthequity (HQY) and Nuvation Bio (NUVB)
Edgewise Therapeutics Analyst Ratings
Edgewise Therapeutics (EWTX) Receives a Buy From Wedbush
Edgewise Therapeutics Analyst Ratings
RBC Capital Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX)
Edgewise Therapeutics Analyst Ratings
Truist Financial Remains a Buy on Edgewise Therapeutics (EWTX)
Buy Rating Affirmed for Edgewise Therapeutics Amid Anticipated Positive Trial Outcomes and Strategic FDA Alignment
Analysts Are Bullish on These Healthcare Stocks: Edgewise Therapeutics (EWTX), Bicycle Therapeutics (BCYC)
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), RayzeBio, Inc. (RYZB) and Edgewise Therapeutics (EWTX)
Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX), Edgewise Therapeutics (EWTX) and Eledon Pharmaceuticals (ELDN)
RBC Capital Sticks to Its Buy Rating for Edgewise Therapeutics (EWTX)
Edgewise Therapeutics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Edgewise Therapeutics (EWTX) and Agilon Health (AGL)
Wedbush Reiterates Outperform on Edgewise Therapeutics, Maintains $27 Price Target
Edgewise Therapeutics Analyst Ratings
Edgewise Therapeutics (EWTX) Receives a Buy From Truist Financial
No Data